Regulatory wins, clinical progress and strategic growth in Q4
Singular Health makes key progress in target US market in Q4 FY26 with growing pipeline and strengthened relationship with Provider Network Solutions Imagion has US FDA approval to start MagSense HER2 Imaging Agent Phase 1b/2 clinical trial for …